- The N-methyl-D-aspartate
receptor (also
known as the NMDA
receptor or
NMDAR), is a
glutamate receptor and
predominantly Ca2+ ion
channel found in neurons...
- antagonize, or
inhibit the
action of, the N-Methyl-D-aspartate
receptor (
NMDAR). They are
commonly used as
anesthetics for
humans and animals; the state...
-
primary target being the GluN1
subunit of the N-methyl-D-aspartate
receptors (
NMDAR) in the brain.
Diagnosis is
typically based on
finding specific antibodies...
-
appears to be a
trigger for anti-
NMDAR encephalitis; most AIE
cases after herpes zoster are now
believed to be anti-
NMDAR encephalitis.
Patients with...
- As such, PCP is a non-competitive NMDA
receptor antagonist. The role of
NMDAR antagonism in the
effect of PCP, ketamine, and
related dissociative agents...
-
BAPTA to
determine whether NMDARs are
required for a
particular cellular process. AP5/APV has also been used to
study NMDAR-dependent LTP in the mammalian...
- lungs. Anti-Ma2, ****ociated with germ-cell
tumours of the testis. Anti-
NMDAR, ****ociated with
tumors of the ovaries,
commonly teratomata.
Since 1999...
- as
potent and
specific antagonists of the N-methyl-D-aspartate
receptor (
NMDAR). They are the only naturally-derived
peptides to do so. The
subtypes of...
-
selective NMDA
receptor (
NMDAR)
antagonist that
competitively inhibits the
glutamate binding site and thus
activation of
NMDAR. It has
anticonvulsant effects...
- ****ociated with
antibodies against the N-methyl-D-aspartate
receptor antibody (
NMDAR) -
often referred to as "anti-NMDA
receptor encephalitis", was identified...
